FDA

Drug Companies Lack Expertise on FDA Medical Device & Development Regs
Medical Devices and Diagnostics Industry
Thu, 02/27/25 - 11:21 am
FDA
Medtech
devices
regulatory
Meeting of US FDA vaccine advisers canceled, committee member says
Investing.com
Wed, 02/26/25 - 10:26 pm
FDA
regulatory
vaccines
Flu
Robert F Kennedy Jr.
Regeneron clears FDA enrollment hurdle for odronextamab review
First Word Pharma
Wed, 02/26/25 - 10:17 pm
Regeneron
FDA
odronextamab
follicular lymphoma
Can Keytruda finally break into early head and neck cancer?
Pharmaphorum
Wed, 02/26/25 - 09:59 am
Merck
Keytruda
head and neck cancer
FDA
Drug compounders sue FDA over declaration ending Wegovy shortage
BioPharma Dive
Tue, 02/25/25 - 10:36 pm
drug compounding
Wegovy
FDA
Hims & Hers Health
FDA brings back some fired device office staff
BioPharma Dive
Tue, 02/25/25 - 10:45 am
FDA
Medtech
devices
HHS
In letter to RFK Jr., Democrats flag threats to drug review process from FDA firings
Fierce Pharma
Mon, 02/24/25 - 05:07 pm
FDA
drug reviews
HHS
Robert F Kennedy Jr.
Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer
BioPharma Dive
Mon, 02/24/25 - 04:52 pm
Pfizer
FDA
Patrizia Cavazzoni
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Fierce Biotech
Mon, 02/24/25 - 11:30 am
Medtronic
Medtech
FDA
neurostimulation
Parkinson's Disease
BrainSense
FDA Clears Entrada Therapeutics' Early-Stage For Potential Treatment Of Duchenne Muscular Dystrophy
Benzinga
Mon, 02/24/25 - 11:15 am
Entrada Therapeutics
ENTR-601-44
DMD
Duchenne Muscular Dystrophy
FDA
Kennedy’s MAHA agenda is tackling ‘conflicts of interest’ — and could take aim at FDA adcomms
Pharma Voice
Mon, 02/24/25 - 09:57 am
Robert F Kennedy Jr.
HHS
FDA
drug approvals
FDA looks at Opdivo/Yervoy in first-line colorectal cancer
Pharmaphorum
Mon, 02/24/25 - 09:56 am
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
FDA
Keytruda
Merck
Deputy director of FDA's CBER departs amid mass exodus at federal health agencies
Fierce Biotech
Sun, 02/23/25 - 10:40 pm
FDA
CBER
Donald Trump
FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol
Benzinga
Sun, 02/23/25 - 10:38 pm
Mirum Pharmaceuticals
FDA
Ctexli
cerebrotendinous xanthomatosis
Device industry scrambles amid concern FDA layoffs will cause delays
BioPharma Dive
Fri, 02/21/25 - 10:52 am
Medtech
devices
FDA
CDRH
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
CNBC
Fri, 02/21/25 - 10:48 am
FDA
drug shortages
Novo Nordisk
Ozempic
Wegovy
FDA staffers told that 'woman,' 'disabled' among banned words - White House says it’s an error
MSN
Fri, 02/21/25 - 10:10 am
FDA
Donald Trump
Women's Health
AstraZeneca deepens China presence with FibroGen deal
BioPharma Dive
Thu, 02/20/25 - 11:52 am
AstraZeneca
FDA
FibroGen
China
roxadustat
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Clinical Trials Arena
Thu, 02/20/25 - 11:33 am
layoffs
FDA
CDC
NIH
DOGE
Boehringer eyes third quarter FDA verdict for oral HER2 drug
Pharmaphorum
Thu, 02/20/25 - 11:29 am
Boehringer Ingelheim
zongertinib
FDA
metastatic non-small cell lung cancer

Pages